Humanigen and Gilead already have their first patient infused in joint clinical study of relapsed lymphoma patients.
Humanigen already has patients being treated in phase 3 clinical trials to prevent and treat cytokine storm in Covid patients.
With patients already being treated I think it will be hard to hold back any news/updates on either. And who knows, we could hear nasdaq news tomorrow. Literally... any moment.
This is a smoldering pile dynamite waiting for the slightest gust of positive news from any direction.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.